Cell Technologies
AB - CalgaryBiotechnology
Focus: Cell Technologies is a publicly traded biotechnology company headquartered in Calgary, AB, specializing in cell therapy for pain and other serious diseases across gene therapy and cell therapy modalities.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Cell Technologies
AI assessmentNot HiringNo open roles listed right now. Follow Cell Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NTCELL
Parkinson's DiseaseClinical Trials (1)
NCT01734733Open-label Investigation of the Safety and Clinical Effects of NTCELL in Patients With Parkinson's Disease
Phase 1/2Help build intelligence for Cell Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.